{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:50Z","timestamp":1786984370106,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.aohep.2020.01.004","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T11:54:59Z","timestamp":1580903699000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population"],"prefix":"10.1016","volume":"19","author":[{"given":"Nicol\u00e1s","family":"Salva-Pastor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Nah\u00fam","family":"L\u00f3pez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto Carlos","family":"Ch\u00e1vez-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Rom\u00e1n","family":"Audifred-Salom\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danniela","family":"Niebla-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Topete-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Pereznu\u00f1ez-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Vidaltamayo-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita Elodia","family":"B\u00e1ez-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misael","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Nu\u00f1o-L\u00e1mbarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.01.004_bib0210","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-Alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.aohep.2020.01.004_bib0215","first-page":"1","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.aohep.2020.01.004_bib0220","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0225","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.aohep.2020.01.004_bib0230","first-page":"267","article-title":"The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider","volume":"12","author":"Salva-Pastor","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.aohep.2020.01.004_bib0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0240","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review. Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome \u2013 Part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aohep.2020.01.004_bib0245","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.aohep.2020.01.004_bib0250","article-title":"Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease","volume":"105445","author":"Salva-Pastor","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.01.004_bib0260","article-title":"Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.01.004_bib0265","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.01.004_bib0270","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/liv.13185","article-title":"Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?","volume":"36","author":"Valenti","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.01.004_bib0275","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40618-017-0782-z","article-title":"Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients","volume":"41","author":"Genazzani","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.aohep.2020.01.004_bib0280","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.01.004_bib0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13658","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: non-invasive tests are enough","volume":"38","author":"Castera","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.01.004_bib0290","first-page":"3218","article-title":"Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan","volume":"12","author":"Abdullah","year":"2017","journal-title":"ARPN J Eng Appl Sci"},{"key":"10.1016\/j.aohep.2020.01.004_bib0295","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jdiacomp.2016.05.014","article-title":"Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome","volume":"30","author":"Mikolasevic","year":"2016","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.aohep.2020.01.004_bib0305","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0310","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2018.09.001","article-title":"PCOS: update and diagnostic approach","volume":"62","author":"Goldrat","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.aohep.2020.01.004_bib0315","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4158\/EP13414.OR","article-title":"Practice patterns in screening for metabolic disease in women with PCOS of diverse race-ethnic backgrounds","volume":"20","author":"Mott","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aohep.2020.01.004_bib0320","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.3748\/wjg.v20.i16.4702","article-title":"Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients","volume":"20","author":"Shen","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5005\/jp-journals-10018-1257","article-title":"Nonalcoholic fatty liver disease: time to take the bull by the horns","volume":"8","author":"Nath","year":"2018","journal-title":"Eur J Hepato-Gastroenterol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0330","article-title":"The interplay between nonalcoholic fatty liver disease and atherosclerotic heart disease","author":"Patel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.01.004_bib0335","doi-asserted-by":"crossref","unstructured":"Gutierrez-Grobe Y, Ponciano-Rodr\u00edguez G, Ramos MH, Uribe M, M\u00e9ndez-S\u00e1nchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol n.d.;9:402\u20139.","DOI":"10.1016\/S1665-2681(19)31616-3"},{"key":"10.1016\/j.aohep.2020.01.004_bib0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome","volume":"6","author":"Karoli","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.aohep.2020.01.004_bib0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719114561552","article-title":"Obesity and PCOS","volume":"22","author":"Schulte","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.aohep.2020.01.004_bib0350","first-page":"37","article-title":"Obesity and polycystic ovary syndrome","volume":"40","author":"Naderpoor","year":"2015","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0355","doi-asserted-by":"crossref","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","article-title":"Adipose tissue, obesity and non-alcoholic fatty liver disease","volume":"42","author":"Polyzos","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0360","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","author":"Polyzos","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.01.004_bib0365","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.rbmo.2018.08.007","article-title":"Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey","volume":"37","author":"Mu","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.aohep.2020.01.004_bib0370","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","author":"Glueck","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.01.004_bib0375","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2020.01.004_bib0380","article-title":"The prevalence of lean\/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"1","author":"Shi","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0385","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.aohep.2020.01.004_bib0390","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.aohep.2020.01.004_bib0395","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.01.004_bib0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18314\/cogo.v1i1.999","article-title":"The association of hispanic ethnicity with nonalcoholic fatty liver disease in polycystic ovary syndrome","volume":"1","author":"Sarkar","year":"2018","journal-title":"Curr Opin Gynecol Obs"},{"key":"10.1016\/j.aohep.2020.01.004_bib0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"key":"10.1016\/j.aohep.2020.01.004_bib0410","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur J Endocrinol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:39:28Z","timestamp":1761647968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120300089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1665268120300089"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.01.004","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}